INSILICO releases full director roster and committee assignments

Bulletin Express07-15

InSilico Medicine Cayman TopCo (英矽智能; “INSILICO”) published an update on 15 July 2026 detailing the composition of its six-member board and the allocation of roles across four key committees.

The board consists of two executive directors—Aleksandrs Zavoronkovs, Ph.D., and Feng Ren, Ph.D.—one non-executive director, Chuen Yan Leung, Ph.D., and three independent non-executive directors: Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi.

Committee leadership is distributed as follows: • Audit Committee: chaired by Roman Kyrychynskyi, with Chuen Yan Leung, Ph.D.; Denitsa Milanova, Ph.D.; and Jingsong Wang, Ph.D. as members. • Remuneration Committee: chaired by Jingsong Wang, Ph.D., with Denitsa Milanova, Ph.D.; Roman Kyrychynskyi; and Feng Ren, Ph.D. serving as members. • Nomination Committee: chaired by Aleksandrs Zavoronkovs, Ph.D., joined by Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi. • ESG Committee: chaired by Feng Ren, Ph.D., with Aleksandrs Zavoronkovs, Ph.D.; Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi as members.

The announcement clarifies committee responsibilities and reinforces the company’s governance structure by designating independent directors to chair both the Audit and Remuneration Committees.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1197117022?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 22:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197117022","market":"us","top_or_hot":-1,"title":"INSILICO releases full director roster and committee assignments","media":"Bulletin Express","content":"<p>InSilico Medicine Cayman TopCo (英矽智能; “INSILICO”) published an update on 15 July 2026 detailing the composition of its six-member board and the allocation of roles across four key committees.</p>\n<p>The board consists of two executive directors—Aleksandrs Zavoronkovs, Ph.D., and Feng Ren, Ph.D.—one non-executive director, Chuen Yan Leung, Ph.D., and three independent non-executive directors: Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi.</p>\n<p>Committee leadership is distributed as follows:\n• Audit Committee: chaired by Roman Kyrychynskyi, with Chuen Yan Leung, Ph.D.; Denitsa Milanova, Ph.D.; and Jingsong Wang, Ph.D. as members.  \n• Remuneration Committee: chaired by Jingsong Wang, Ph.D., with Denitsa Milanova, Ph.D.; Roman Kyrychynskyi; and Feng Ren, Ph.D. serving as members.  \n• Nomination Committee: chaired by Aleksandrs Zavoronkovs, Ph.D., joined by Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi.  \n• ESG Committee: chaired by Feng Ren, Ph.D., with Aleksandrs Zavoronkovs, Ph.D.; Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi as members.</p>\n<p>The announcement clarifies committee responsibilities and reinforces the company’s governance structure by designating independent directors to chair both the Audit and Remuneration Committees.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INSILICO releases full director roster and committee assignments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINSILICO releases full director roster and committee assignments\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-15 22:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>InSilico Medicine Cayman TopCo (英矽智能; “INSILICO”) published an update on 15 July 2026 detailing the composition of its six-member board and the allocation of roles across four key committees.</p>\n<p>The board consists of two executive directors—Aleksandrs Zavoronkovs, Ph.D., and Feng Ren, Ph.D.—one non-executive director, Chuen Yan Leung, Ph.D., and three independent non-executive directors: Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi.</p>\n<p>Committee leadership is distributed as follows:\n• Audit Committee: chaired by Roman Kyrychynskyi, with Chuen Yan Leung, Ph.D.; Denitsa Milanova, Ph.D.; and Jingsong Wang, Ph.D. as members.  \n• Remuneration Committee: chaired by Jingsong Wang, Ph.D., with Denitsa Milanova, Ph.D.; Roman Kyrychynskyi; and Feng Ren, Ph.D. serving as members.  \n• Nomination Committee: chaired by Aleksandrs Zavoronkovs, Ph.D., joined by Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi.  \n• ESG Committee: chaired by Feng Ren, Ph.D., with Aleksandrs Zavoronkovs, Ph.D.; Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi as members.</p>\n<p>The announcement clarifies committee responsibilities and reinforces the company’s governance structure by designating independent directors to chair both the Audit and Remuneration Committees.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1197117022","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197117022","pubTimestamp":1784125328,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InSilico Medicine Cayman TopCo (英矽智能; “INSILICO”) published an update on 15 July 2026 detailing the composition of its six-member board and the allocation of roles across four key committees. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"INSILICO 发布完整的董事名单和委员会任务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"InSilico Medicine Cayman TopCo (英矽智能; “INSILICO”) published an update on 15 July 2026 detailing the composition of its six-member board and the allocation of roles across four key committees.\nThe board consists of two executive directors—Aleksandrs Zavoronkovs, Ph.D., and Feng Ren, Ph.D.—one non-executive director, Chuen Yan Leung, Ph.D., and three independent non-executive directors: Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi.\nCommittee leadership is distributed as follows:\n• Audit Committee: chaired by Roman Kyrychynskyi, with Chuen Yan Leung, Ph.D.; Denitsa Milanova, Ph.D.; and Jingsong Wang, Ph.D. as members.  \n• Remuneration Committee: chaired by Jingsong Wang, Ph.D., with Denitsa Milanova, Ph.D.; Roman Kyrychynskyi; and Feng Ren, Ph.D. serving as members.  \n• Nomination Committee: chaired by Aleksandrs Zavoronkovs, Ph.D., joined by Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi.  \n• ESG Committee: chaired by Feng Ren, Ph.D., with Aleksandrs Zavoronkovs, Ph.D.; Denitsa Milanova, Ph.D.; Jingsong Wang, Ph.D.; and Roman Kyrychynskyi as members.\nThe announcement clarifies committee responsibilities and reinforces the company’s governance structure by designating independent directors to chair both the Audit and Remuneration Committees.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1197117022","isCrawlerRequest":true}